Table 2. Clinicopathological characteristics of patients between with and without preoperative treatment.

Characteristics	With preoperative treatment (n=109)	Without preoperative treatment (n=50)	P value
Age (years)	57 [27–69]	57 [41–66]	0.533
Sex (male/female)	79/30	35/15	0.850
Etiology			0.215
Viral hepatitis C	71	25
Viral hepatitis B	28	15
Viral hepatitis C/B	2	3
Others	8	7
AFP	29.6 (1.5–12,727)	25 (1.3–2,912)	0.485
DCP	42 [5–20,600]	41 [5–1,310]	0.349
Child Pugh (A/B/C)	19/39/51	1/20/29	0.232
MELD	14.8 [4–41]	16.5 [8–39]	0.006
Maximum tumor size (cm)	2 (0.4–3)	2 (0.8–3)	0.096
Classification	Well 16/mod 73/poor 20	Well 7/mod 39/poor 4	0.101
Number of tumors	2 [1–186]	2 [1–5]	0.312
Milan criteria met	78 (72%)	46 (92%)	0.004
Kyoto criteria met	88 (81%)	44 (88%)	0.363

AFP, alpha-fetoprotein; DCP, des-gamma-carboxy prothrombin; MELD, model for end-stage liver disease.